![Formycon AG logo](/logos/FYB.DE.webp)
Formycon AG
FSX:FYB.DE
Overview | Financials
Company Name | Formycon AG |
Symbol | FYB.DE |
Currency | EUR |
Price | 50 |
Market Cap | 882,845,000 |
Dividend Yield | 0% |
52-week-range | 37.65 - 67.8 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Stefan Glombitza |
Website | https://www.formycon.com |
An error occurred while fetching data.
About Formycon AG
Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of inflammatory diseases, such
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD